- call +1-201-465-4211
- email sales@mrinsights.biz
Panic disorder is an anxiety disorder characterized by reoccurring unexpected panic attacks.
Scope of the Report:
This report studies the Panic Disorders market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Panic Disorders market by product type and applications/end industries.
Panic disorder is usually treated with counselling and medications. The type of counselling used is typically cognitive behavioral therapy which is effective in more than half of people. Medications used include antidepressants and occasionally benzodiazepines or beta blockers.
The global Panic Disorders market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Panic Disorders.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Teva Pharmaceutical
Sun Pharmaceuticals
Mylan
AstraZeneca
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Anti-Depressants
Benzodiazepines
Market Segment by Applications, can be divided into
Hospital Pharmacies
Retail Pharmacies
Drug Stores
E-Commerce
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Panic Disorders Market Overview
1.1 Product Overview and Scope of Panic Disorders
1.2 Classification of Panic Disorders by Types
1.2.1 Global Panic Disorders Revenue Comparison by Types (2017-2023)
1.2.2 Global Panic Disorders Revenue Market Share by Types in 2017
1.2.3 Anti-Depressants
1.2.4 Benzodiazepines
1.3 Global Panic Disorders Market by Application
1.3.1 Global Panic Disorders Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Drug Stores
1.3.5 E-Commerce
1.4 Global Panic Disorders Market by Regions
1.4.1 Global Panic Disorders Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Panic Disorders Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Panic Disorders Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Panic Disorders Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Panic Disorders Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Panic Disorders Status and Prospect (2013-2023)
1.5 Global Market Size of Panic Disorders (2013-2023)
2 Manufacturers Profiles
2.1 Teva Pharmaceutical
2.1.1 Business Overview
2.1.2 Panic Disorders Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Teva Pharmaceutical Panic Disorders Revenue, Gross Margin and Market Share (2016-2017)
2.2 Sun Pharmaceuticals
2.2.1 Business Overview
2.2.2 Panic Disorders Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Sun Pharmaceuticals Panic Disorders Revenue, Gross Margin and Market Share (2016-2017)
2.3 Mylan
2.3.1 Business Overview
2.3.2 Panic Disorders Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Mylan Panic Disorders Revenue, Gross Margin and Market Share (2016-2017)
2.4 AstraZeneca
2.4.1 Business Overview
2.4.2 Panic Disorders Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 AstraZeneca Panic Disorders Revenue, Gross Margin and Market Share (2016-2017)
3 Global Panic Disorders Market Competition, by Players
3.1 Global Panic Disorders Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Panic Disorders Players Market Share
3.2.2 Top 10 Panic Disorders Players Market Share
3.3 Market Competition Trend
4 Global Panic Disorders Market Size by Regions
4.1 Global Panic Disorders Revenue and Market Share by Regions
4.2 North America Panic Disorders Revenue and Growth Rate (2013-2018)
4.3 Europe Panic Disorders Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Panic Disorders Revenue and Growth Rate (2013-2018)
4.5 South America Panic Disorders Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Panic Disorders Revenue and Growth Rate (2013-2018)
5 North America Panic Disorders Revenue by Countries
5.1 North America Panic Disorders Revenue by Countries (2013-2018)
5.2 USA Panic Disorders Revenue and Growth Rate (2013-2018)
5.3 Canada Panic Disorders Revenue and Growth Rate (2013-2018)
5.4 Mexico Panic Disorders Revenue and Growth Rate (2013-2018)
6 Europe Panic Disorders Revenue by Countries
6.1 Europe Panic Disorders Revenue by Countries (2013-2018)
6.2 Germany Panic Disorders Revenue and Growth Rate (2013-2018)
6.3 UK Panic Disorders Revenue and Growth Rate (2013-2018)
6.4 France Panic Disorders Revenue and Growth Rate (2013-2018)
6.5 Russia Panic Disorders Revenue and Growth Rate (2013-2018)
6.6 Italy Panic Disorders Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Panic Disorders Revenue by Countries
7.1 Asia-Pacific Panic Disorders Revenue by Countries (2013-2018)
7.2 China Panic Disorders Revenue and Growth Rate (2013-2018)
7.3 Japan Panic Disorders Revenue and Growth Rate (2013-2018)
7.4 Korea Panic Disorders Revenue and Growth Rate (2013-2018)
7.5 India Panic Disorders Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Panic Disorders Revenue and Growth Rate (2013-2018)
8 South America Panic Disorders Revenue by Countries
8.1 South America Panic Disorders Revenue by Countries (2013-2018)
8.2 Brazil Panic Disorders Revenue and Growth Rate (2013-2018)
8.3 Argentina Panic Disorders Revenue and Growth Rate (2013-2018)
8.4 Colombia Panic Disorders Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Panic Disorders by Countries
9.1 Middle East and Africa Panic Disorders Revenue by Countries (2013-2018)
9.2 Saudi Arabia Panic Disorders Revenue and Growth Rate (2013-2018)
9.3 UAE Panic Disorders Revenue and Growth Rate (2013-2018)
9.4 Egypt Panic Disorders Revenue and Growth Rate (2013-2018)
9.5 Nigeria Panic Disorders Revenue and Growth Rate (2013-2018)
9.6 South Africa Panic Disorders Revenue and Growth Rate (2013-2018)
10 Global Panic Disorders Market Segment by Type
10.1 Global Panic Disorders Revenue and Market Share by Type (2013-2018)
10.2 Global Panic Disorders Market Forecast by Type (2018-2023)
10.3 Anti-Depressants Revenue Growth Rate (2013-2023)
10.4 Benzodiazepines Revenue Growth Rate (2013-2023)
11 Global Panic Disorders Market Segment by Application
11.1 Global Panic Disorders Revenue Market Share by Application (2013-2018)
11.2 Panic Disorders Market Forecast by Application (2018-2023)
11.3 Hospital Pharmacies Revenue Growth (2013-2018)
11.4 Retail Pharmacies Revenue Growth (2013-2018)
11.5 Drug Stores Revenue Growth (2013-2018)
11.6 E-Commerce Revenue Growth (2013-2018)
12 Global Panic Disorders Market Size Forecast (2018-2023)
12.1 Global Panic Disorders Market Size Forecast (2018-2023)
12.2 Global Panic Disorders Market Forecast by Regions (2018-2023)
12.3 North America Panic Disorders Revenue Market Forecast (2018-2023)
12.4 Europe Panic Disorders Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Panic Disorders Revenue Market Forecast (2018-2023)
12.6 South America Panic Disorders Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Panic Disorders Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Panic Disorders Picture
Table Product Specifications of Panic Disorders
Table Global Panic Disorders and Revenue (Million USD) Market Split by Product Type
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
